OCRELIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11237KMP | OCRELIZUMAB ocrelizumab 300 mg/10 mL injection, 10 mL vial (PI, CMI) |
2 | 2 | 0 | $16705.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Ocrevus |
OCRELIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11242QMP | OCRELIZUMAB ocrelizumab 300 mg/10 mL injection, 10 mL vial (PI, CMI) |
2 | 2 | 0 | $16656.36 | $31.60 | $31.60 |
| Available brands | |||||||
| Ocrevus |
- Legend
- MPMedical Practitioner




